Clinical Trials Directory

Trials / Terminated

TerminatedNCT00506363

Safety and Efficacy of Different Onset Times of Treatment With Pulsed Dye Laser on Improvement of Surgical Scars

The Effect of Different Onset Times of Treatment With 595-nm Pulsed Dye Laser on Improvement of Surgical Scars: A Double Blind Randomised Clinical Trial

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Tehran University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The appearance of skin after surgery plays an important role in patient's self confidence and life style. In fact, Keloids and hypertrophic scars are abnormal wound responses appearing in predisposed individuals after surgery. Among different kind of lasers, used to improve the appearance of hypertrophic scars and keloids, pulsed dye laser is now being used successfully in treatment of scars. Pulsed dye laser is effective in improving the color, height, texture, and elasticity of scars. Also, treatment with this technique is noninvasive, minimally uncomfortable, and requires no anesthesia. This study will assess the efficacy and safety of different onset times of treatment with pulsed dye laser on improvement of surgical scars.

Conditions

Interventions

TypeNameDescription
PROCEDUREpulsed dye laser therapyEach scar will be divided into 3 equal parts. One part will be randomly allocated to be treated with pulsed dye laser and dynamic cooling device on the day of suture removal. Another part will be treated with pulsed dye laser and dynamic cooling device 2 months after suture removal. Only dynamic cooling device will be used for remaining part serving as control. Treatment will repeat for 6 sessions at 3 weeks intervals.

Timeline

Start date
2008-01-01
Primary completion
2008-12-01
Completion
2009-01-01
First posted
2007-07-25
Last updated
2009-10-06

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT00506363. Inclusion in this directory is not an endorsement.